ResearcherCedars-Sinai Medical CenterActive in the last 2 years
Jian Tajbakhsh
Matched on ORCID iD 0009-0005-0293-3490; OpenAlex author ID A5024899896. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 3
- A Clinical Laboratory Improvement Amendments/College of American Pathologists-Compliant Noninvasive Laboratory-Developed Test for Early Detection of Pancreatic… Co-author DOI 10.1016/j.jmoldx.2024.10.001↗
- Evaluation of urinary C-reactive protein as an early detection biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2024.1450326↗
- An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice. Co-author DOI 10.1053/j.gastro.2018.08.028↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stephen Jacob Pandol · 3 shared papers, 2018–2025 · strength 0.52
- Paper A Clinical Laboratory Improvement Amendments/College of American Pathologists-Compliant Noninvasive Laboratory-Develope… DOI 10.1016/j.jmoldx.2024.10.001↗
- Paper Evaluation of urinary C-reactive protein as an early detection biomarker for pancreatic ductal adenocarcinoma. DOI 10.3389/fonc.2024.1450326↗
- Paper An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice. DOI 10.1053/j.gastro.2018.08.028↗
- Silvana Debernardi · 2 shared papers, 2024–2025 · strength 0.46
- Paper A Clinical Laboratory Improvement Amendments/College of American Pathologists-Compliant Noninvasive Laboratory-Develope… DOI 10.1016/j.jmoldx.2024.10.001↗
- Paper Evaluation of urinary C-reactive protein as an early detection biomarker for pancreatic ductal adenocarcinoma. DOI 10.3389/fonc.2024.1450326↗
- Nirdesh K. Gupta · 2 shared papers, 2024–2025 · strength 0.46
- Paper A Clinical Laboratory Improvement Amendments/College of American Pathologists-Compliant Noninvasive Laboratory-Develope… DOI 10.1016/j.jmoldx.2024.10.001↗
- Paper Evaluation of urinary C-reactive protein as an early detection biomarker for pancreatic ductal adenocarcinoma. DOI 10.3389/fonc.2024.1450326↗
- Tatjana Crnogorac‐Jurcevic · 2 shared papers, 2024–2025 · strength 0.46
- Paper A Clinical Laboratory Improvement Amendments/College of American Pathologists-Compliant Noninvasive Laboratory-Develope… DOI 10.1016/j.jmoldx.2024.10.001↗
- Paper Evaluation of urinary C-reactive protein as an early detection biomarker for pancreatic ductal adenocarcinoma. DOI 10.3389/fonc.2024.1450326↗
- Oleg B. Blyuss · 2 shared papers, 2024–2025 · strength 0.46
- Paper A Clinical Laboratory Improvement Amendments/College of American Pathologists-Compliant Noninvasive Laboratory-Develope… DOI 10.1016/j.jmoldx.2024.10.001↗
- Paper Evaluation of urinary C-reactive protein as an early detection biomarker for pancreatic ductal adenocarcinoma. DOI 10.3389/fonc.2024.1450326↗
- Simon K. Lo · 1 shared paper, 2025 · strength 0.26
- Nurshad Ali · 1 shared paper, 2024 · strength 0.20
- Stephen P. Pereira · 1 shared paper, 2024 · strength 0.20
- Neil A. Bhowmick · 1 shared paper, 2018 · strength 0.07
- Qiang Wang · 1 shared paper, 2018 · strength 0.07
- Aida Habtezion · 1 shared paper, 2018 · strength 0.07
- László G. Boros · 1 shared paper, 2018 · strength 0.07
- Richard Tuli · 1 shared paper, 2018 · strength 0.07
- Mouad Edderkaoui · 1 shared paper, 2018 · strength 0.07
- Ramachandran Murali · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.